Lisata Therapeutics, Inc. (LSTA) NASDAQ
5.03
+0.01(+0.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.03
+0.01(+0.20%)
Currency In USD
| Market Cap | 16.16M |
| Enterprise Value | 201,820 |
| P/E Ratio | -2.63 |
| PEG Ratio | -0.26 |
| Price/Sales Ratio | 260.99 |
| Price/Book Ratio | 2.94 |
| Enterprise/Revenue | 167.13 |
| Enterprise/EBITDA | -1.94 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -97.56 |
| Operating Margin | -88.99 |
| Return On Assets | -0.93 |
| Return On Equity | -0.84 |
| Revenue | 170,000 |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | -16.59M |
| Diluted EPS | -1.91 |
| Total Cash | 15.96M |
| Total Cash/Share | 1.84 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.76 |
| Book Value Per Share | 1.68 |
| 52-Week Change | 116.81 |
| 52-Week High | 5.07 |
| 52-Week Low | 1.81 |
| Moving Average 50 Days | 3.81 |
| Moving Average 200 Days | 2.76 |
| Average Volume | 172,345 |
| Shares Outstanding | 8.82M |
| % Held by Institutions | 8.18 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | September 15, 2022 |